Delivra Health Brands (TSE:DHB)
:DHB
DHB Stock Chart & Stats
C$0.15
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.15
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.13 - C$0.37
Previous CloseN/A
Volume20.60K
Average Volume (3M)26.13K
Market Cap
C$4.69M
Enterprise ValueC$3.72M
Total Cash (Recent Filing)C$3.23M
Total Debt (Recent Filing)C$2.26M
Price to Earnings (P/E)―
Beta1.85
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding31,261,782
10 Day Avg. Volume58,945
30 Day Avg. Volume26,134
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.30
Price to Sales (P/S)0.41
P/FCF Ratio-7.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.60Price Target Upside300.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$14.97M
Bulls Say, Bears Say
Bulls Say
Gross Margin ImprovementSustained gross margins around 50% indicate the core product portfolio has favorable unit economics. Over a 2–6 month horizon, healthy gross margins provide a durable buffer versus input cost swings, improve the path to operating profitability as fixed costs are absorbed, and support reinvestment in marketing and distribution.
Manageable LeverageLeverage at roughly 0.5–0.6 with positive equity provides a reasonable capital structure for a small issuer. This level of debt is unlikely to force immediate restructuring, preserving strategic optionality for working capital or targeted investment, and reduces near-term solvency risk relative to highly leveraged peers.
Multi-year Revenue ExpansionConsistent revenue expansion over multiple years signals product-market fit and effective distribution (retail and e-commerce). Even with a recent TTM dip, the structural growth trajectory supports scale benefits: fixed-cost leverage, improved bargaining power with retailers, and potential margin upside as sales normalize.
Bears Say
Ongoing UnprofitabilityPersistent negative margins mean the business still consumes shareholder capital rather than generating it. Sustained unprofitability constrains reinvestment, increases reliance on external financing or dilution, and creates execution risk—profits must be achieved to sustainably fund growth and CEO strategy over the coming months.
Volatile Cash GenerationIrregular and recently negative cash flows reduce financial flexibility and raise fundraising risk. Volatile cash generation makes planning for inventory, marketing, and retailer terms harder, increases the probability of equity dilution or costly financing, and limits the company's ability to capitalize on growth opportunities.
Negative Return On EquityConsistently negative ROE implies the company is eroding shareholder value rather than creating it. Over months, continued negative ROE pressures the equity base, undermines investor confidence, and could force strategic shifts (cost cuts or asset sales) if profitability trends do not reverse.
Delivra Health Brands News
DHB FAQ
What was Delivra Health Brands’s price range in the past 12 months?
Delivra Health Brands lowest stock price was C$0.13 and its highest was C$0.37 in the past 12 months.
What is Delivra Health Brands’s market cap?
Delivra Health Brands’s market cap is C$4.69M.
When is Delivra Health Brands’s upcoming earnings report date?
Delivra Health Brands’s upcoming earnings report date is May 27, 2026 which is in 48 days.
How were Delivra Health Brands’s earnings last quarter?
Delivra Health Brands released its earnings results on Feb 27, 2026. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Delivra Health Brands overvalued?
According to Wall Street analysts Delivra Health Brands’s price is currently Undervalued.
Does Delivra Health Brands pay dividends?
Delivra Health Brands does not currently pay dividends.
What is Delivra Health Brands’s EPS estimate?
Delivra Health Brands’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Delivra Health Brands have?
Delivra Health Brands has 31,261,782 shares outstanding.
What happened to Delivra Health Brands’s price movement after its last earnings report?
Delivra Health Brands reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Delivra Health Brands?
Currently, no hedge funds are holding shares in TSE:DHB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Delivra Health Brands
Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. The company is involved in selling of cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It offers its products under LivRelief, Dream Water, and LivRelief infused brand names. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.
DHB Stock 12 Month Forecast
Average Price Target
C$0.60
▲(300.00% Upside)
Technical Analysis
Options Prices
Currently, No data available
---